EURURO Vol. 73 No. 1
|
Platinum Opinion |
1 |
|
New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far? |
1 |
|
Platinum Priorities |
4 |
|
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201) |
4 |
|
Brief Correspondence |
9 |
|
Innovative Therapies to Overcome Resistance to Enzalutamide: Perspective on the Use of Darolutamide |
9 |
|
Prostate Cancer |
11 |
|
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review |
11 |
|
Randomised Controlled Trials Remain the Key to Progress in Localised Prostate Cancer |
21 |
|
Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS) |
23 |
|
The “PROMIS” of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? |
31 |
|
Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients? |
33 |
|
Erectile Function Recovery After Surgery in Young Men with Low-risk Prostate Cancer: Probably Not Just a Matter of Age, Certainly Not the Main Pointof Discussion |
38 |
|
Bladder Cancer |
40 |
|
Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review |
40 |
|
Bladder Cancer in the Elderly |
51 |
|
Kidney Cancer |
53 |
|
Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial |
53 |
|
Should Urologists Abandon the Use of Mannitol During Partial Nephrectomy? |
60 |
|
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results |
62 |
|
Are We Ready for Adjuvant Sunitinib in High-risk Renal Cell Carcinoma? |
69 |
|
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling |
71 |
|
Papillary Renal Cell Carcinoma: A Family Portrait |
79 |
|
Prostatic Disease |
81 |
|
Diagnostic Performance of Magnetic Resonance Imaging for the Detection of Bone Metastasis in Prostate Cancer: A Systematic Review and Meta-analysis |
81 |
|
Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History |
92 |
|
Renal Disease |
94 |
|
The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review |
94 |
|
Renal Transplantation After Treatment for a Urological Cancer: Who and When? Does Evidence Help for a Challenge? |
109 |
|
Guidelines |
111 |
|
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update |
111 |
|
Surgery in Motion |
123 |
|
Lateral-based Anterior Vaginal Wall Flap in the Treatment of Female Urethral Stricture: Efficacy and Safety |
123 |
|
Original Article |
129 |
|
Prostate Cancer |
129 |
|
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically LocalizedDisease |
129 |
|
Words of Wisdom |
139 |
|
Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient-specific Molds to Correlate Images with Whole-mount Pathology |
139 |
|
Re: Impact of Radical Prostatectomy on Long-term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration |
140 |
|
Re: Salvage High-intensity Focused Ultrasound (HIFU) for Locally Recurrent Prostate Cancer After Failed Radiation Therapy: Multi-institutional Analysis of 418 Patients |
140 |
|
Re: Metastasis-free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer |
141 |
|
Re: Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer |
142 |
|
Re: Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer |
143 |
|
Research Letters |
145 |
|
[¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis |
145 |
|
Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question! |
147 |
|
Letters to the Editor published online |
149 |
|
Re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402–7 |
153 |
|
Congress Calendar |
157 |